Stay updated on Ph 3 B-VEC Efficacy & Safety in DEB Clinical Trial
Sign up to get notified when there's something new on the Ph 3 B-VEC Efficacy & Safety in DEB Clinical Trial page.

Latest updates to the Ph 3 B-VEC Efficacy & Safety in DEB Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe PubMed publications description was clarified to indicate auto-fill from PubMed. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved a general government funding/operating status notice from the page, with no impact on the study's description, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedBoth screenshots show the same study record (NCT04491604) with identical core sections (title, brief summary, eligibility criteria, study design, and outcomes). Any observed differences appear to be cosmetic rather than content-related.SummaryDifference0.5%

- Check71 days agoChange DetectedMajor update: version bumped to v3.2.0 with an important government-operating-status notice and a new term (Epidermolysis bullosa dystrophica); old version v3.1.0 removed. If this page is disease-related, the new term may affect terminology or search indexing.SummaryDifference4%

- Check78 days agoChange DetectedThe page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs) have been removed.SummaryDifference0.6%

- Check93 days agoChange DetectedThe page version was updated from v3.0.1 to v3.0.2, and the 'Back to Top' link/button was removed.SummaryDifference0.2%

Stay in the know with updates to Ph 3 B-VEC Efficacy & Safety in DEB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ph 3 B-VEC Efficacy & Safety in DEB Clinical Trial page.